General Information
Intarcia DM2 107
A Randomized, Multicenter Study to Evaluate Cardiovascular Outcomes with ITCA 650 in Patients Treated with Standard of Care for Type 2 Diabetes
| Protocol | ITCA 650-CLP-107 |
|---|---|
| Identifier | Site No: 1254 |
| UID | e2c4d194-b57c-446f-93a0-2cd82aadfaa0 |
| Status | Done - Archived |
| Phase | 3/4 |
| Category | Diabetes Type 2 |
| Launch Year | 2013 |
| NCT Number | - |
| Created | 2013-07-23 17:02 |
| Last Updated | 2013-07-23 17:02 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | 2013-09-11 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2013-09-11 | No |
| PI Meeting Start | 2013-08-09 | No |
| PI Meeting End | 2013-08-10 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-04-19 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Barnett, Omar | OBarnett | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Intarcia Therapeutics, Inc. |
|---|---|
| Division | Intarcia Therapeutics, Inc. |
| Team | Intarcia Therapeutics, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
